Cancer Stem Cells Shift Metabolite Acetyl‐Coenzyme A to Abrogate the Differentiation of CD103 <sup>+</sup> T CellsJiaxin Lei(Soochow University), Zhenke Wen(Soochow University)Advanced ScienceNovember 23, 202510.1002/advs.202513535Cited by 0SaveCiteExport RISWatch citationsRelated PapersCancer CD39 drives metabolic adaption and mal-differentiation of CD4+ T cells in patients with non-small-cell lung cancer|Cell Death and Disease|2023|24Lipogenesis promotes mitochondrial fusion and maintains cancer stemness in human NSCLC|JCI Insight|2023|21Notch1 hyperactivity drives ubiquitination of NOX2 and dysfunction of CD8+ regulatory T cells in patients with systemic lupus erythematosus|Lara D. Veeken|2024|3